This dataset contains information about various genetic and diagnostic tests, detailing their purpose, the population they serve, and their approval status. It includes a variety of tests aimed at assessing genetic risks, carrier statuses, and hereditary conditions, with many tests specifically focused on cancer and other serious health issues.
Test Name | Type of Testing | Indication | Population Type | Associated Conditions | Company | Approval Status |
---|---|---|---|---|---|---|
BRCA1 & BRCA2 | Genetic | Breast Cancer Risk | General | Breast and Ovarian Cancer | Myriad Genetics | FDA Approved |
23andMe Ancestry | Ancestry | Genetic Ancestry | General | Trait Analysis | 23andMe | Not Required |
Genetic Carrier Screening | Carrier | Carrier Status | General | Cystic Fibrosis, SMA | Invitae | FDA Approved |
Clarity Genetic Test | Diagnostic | Hereditary Cancer | Family | Various Cancers | Invitae | FDA Approved |
Cardio genomic panel | Genetic | Cardiovascular Disease | Cardiac | Hypertrophic Cardiomyopathy | GeneDx | FDA Approved |
Whole Exome Sequencing | Genetic | Rare Disease Diagnosis | General | Various Rare Diseases | Ambry Genetics | Research Use |
ExomePlus | Genetic | Hereditary Disorder | General | Genetic Syndromes | Ambry Genetics | FDA Approved |
PGT-M | Reproductive | Embryo Testing | Pregnant | Genetic Disorders | Natera | FDA Approved |
MTHFR Gene Test | Genetic | Thrombophilia Risk | General | MTHFR Mutation Effects | Various Labs | FDA Approved |
Genomic Health BreastRecurrence Score | Diagnostic | Breast Cancer Recurrence | Oncology | Breast Cancer Risk | Genomic Health | FDA Approved |
Carrier Screening for 50 Diseases | Carrier | Carrier Status | General | Various Genetic Disorders | Fulgent Genetics | FDA Approved |
Actionable Insights for Hereditary Cancer | Diagnostic | Hereditary Cancer Risk | Family | Various Cancers | Foundation Medicine | FDA Approved |
Disease-Specific Panels | Genetic | Specific Conditions | Special Population | Specific Rare Diseases | Multiple Labs | Research Use |
Familial Hypercholesterolemia Testing | Genetic | Cholesterol Disorders | General | Heart Disease Risk | Various Labs | FDA Approved |
SNP Testing | Ancestry | Genetic Variants | General | Trait Analysis | 23andMe | Not Required |
Neurogenetics Panel | Genetic | Neurological Disorders | General | Neurodegenerative Diseases | GeneDx | FDA Approved |
Pharmacogenomic Testing | Pharmacogenomic | Drug Response | General | Medication Metabolism | Various Labs | FDA Approved |
Ancestry Composition Report | Ancestry | Ethnic Ancestry Composition | General | Genetic Traits | Ancestry.com | Not Required |
Hemoglobinopathies Testing | Carrier | Sickle Cell Anemia, Thalassemia | Ethnic Groups | Sickle Cell Disease | Various Labs | FDA Approved |
Prenatal Genetic Testing | Prenatal | Fetal Genetic Conditions | Pregnant | Chromosomal Abnormalities | Natera | FDA Approved |
Next Generation Sequencing Panels | Genetic | Broad Genetic Conditions | General | Various Genetic Disorders | Ambry Genetics | FDA Approved |
Hereditary Hemochromatosis Test | Genetic | Iron Overload Disorders | General | Hemochromatosis | Various Labs | FDA Approved |
Microdeletion/Microduplication Testing | Genetic | Chromosomal Disorders | General | Genetic Syndromes | Ambry Genetics | FDA Approved |
Cardiac Arrhythmia Panel | Genetic | Heart Rhythm Disorders | Cardiac | Arrhythmias | GeneDx | FDA Approved |
Genetic Test for Gaucher Disease | Genetic | Metabolic Disorders | General | Gaucher's Disease | Various Labs | FDA Approved |
Genetic Testing for Cystic Fibrosis | Carrier | Cystic Fibrosis Carrier Status | General | Cystic Fibrosis | Invitae | FDA Approved |
Non-Invasive Prenatal Testing | Prenatal | Fetal Chromosomal Abnormalities | Pregnant | Down Syndrome | Natera | FDA Approved |
Genetic Counseling Consultation | Counseling | Pre/Post Test Counseling | General | Genetic Testing Education | Various Providers | Not Applicable |
Testing for Lynch Syndrome | Genetic | Colorectal Cancer Risk | Family | Lynch Syndrome | Invitae | FDA Approved |
Genetic Testing for Spinal Muscular Atrophy | Carrier | SMA Carrier Status | General | SMA | Invitae | FDA Approved |
Fragile X Syndrome Testing | Genetic | Intellectual Disability | General | Fragile X Syndrome | Various Labs | FDA Approved |
Familial Mediterranean Fever Testing | Genetic | Auto Inflammatory Syndromes | Ethnic Groups | FMF | Various Labs | FDA Approved |
Genetic Testing for Ellis-van Creveld Syndrome | Genetic | Skeletal Disorders | General | Ellis-van Creveld Syndrome | Various Labs | FDA Approved |
Alzheimer's Genetic Risk Testing | Genetic | Alzheimer's Disease Risk | General | AD Risk Factors | Various Labs | FDA Approved |
ENDURE Genetic Testing | Diagnostic | Childhood Genetic Disorders | Pediatrics | Various Disorders | Invitae | FDA Approved |
Expanded Carrier Screening | Carrier | Broad Disease Carrier Status | General | Various Genetic Disorders | Myriad Genetics | FDA Approved |
Genetic Testing for Neurofibromatosis | Genetic | Tumor Syndromes | General | Neurofibromatosis | Invitae | FDA Approved |
Testing for Beta Thalassemia | Genetic | Blood Disorders | General | Thalassemia | Various Labs | FDA Approved |
Genetic Test for Tay-Sachs Disease | Carrier | Tay-Sachs Carrier Status | Ethnic Groups | Tay-Sachs Disease | Various Labs | FDA Approved |
Genetic Testing for LADD Syndrome | Genetic | Entodermal Sinus Tumor Risk | General | LADD Syndrome | Various Labs | FDA Approved |
TP53 Testing for Li-Fraumeni Syndrome | Genetic | Cancer Risk Assessment | Family | Li-Fraumeni Syndrome | Myriad Genetics | FDA Approved |
Duchenne Muscular Dystrophy Testing | Genetic | Muscular Disorders | General | Duchenne Muscular Dystrophy | Various Labs | FDA Approved |
Germline Genetic Testing | Genetic | Inherited Cancer Risks | Family | Various Cancers | Myriad Genetics | FDA Approved |
Hormonal Genomic Testing | Pharmacogenomic | Hormonal Response | General | Endocrine Disorders | GeneDx | FDA Approved |
Medication Couple Genotyping | Pharmacogenomic | Drug Interaction Risks | General | Medication Efficacy | Various Labs | FDA Approved |
Hereditary Prostate Cancer Gene Panel | Genetic | Prostate Cancer Risk | Family | Prostate Cancer | Invitae | FDA Approved |
Genetic Testing for Alport Syndrome | Genetic | Kidney Disorders | General | Alport Syndrome | GeneDx | FDA Approved |
Family Tree Genetic Access Testing | Ancestry | Ancestry Information | General | Family History | FamilySearch | Not Required |
Urothelial Carcinoma Risk Testing | Genetic | Bladder Cancer Risk | General | Urothelial Carcinoma | GeneDx | FDA Approved |
Genetic Test for Osteogenesis Imperfecta | Genetic | Bone Disorders | General | Brittle Bone Disease | Various Labs | FDA Approved |
Comprehensive Metabolic Testing | Genetic | Metabolic Disorders | General | Various Metabolic Conditions | Ambry Genetics | FDA Approved |
Test for Methylenetetrahydrofolate Reductase | Genetic | Folic Acid Metabolism | General | MTHFR Variants | Various Labs | FDA Approved |
Genetic Test for Netherton Syndrome | Genetic | Skin Disorders | General | Netherton Syndrome | Various Labs | FDA Approved |
Next Generation Sequencing for Mendelian Disorders | Genetic | Inherited Conditions | General | Mendelian Disorders | GeneDx | FDA Approved |
Genetic Testing for Usher Syndrome | Genetic | Hearing and Vision Disorders | General | Usher Syndrome | Various Labs | FDA Approved |
Testing for von Willebrand Disease | Genetic | Bleeding Disorders | General | Von Willebrand Disease | Various Labs | FDA Approved |
Genetic Testing for Progeria | Genetic | Aging Disorders | General | Progeria Syndrome | GeneDx | FDA Approved |
Comprehensive Autism Spectrum Disorder Testing | Genetic | Developmental Disorders | General | ASD | GeneDx | FDA Approved |
Genetic Testing for HHT | Genetic | Vascular Disorders | General | Hereditary Hemorrhagic Telangiectasia | Various Labs | FDA Approved |
Genetic Testing for MCAD Deficiency | Genetic | Metabolic Disorders | General | Medium-Chain Acyl-CoA Dehydrogenase Deficiency | Various Labs | FDA Approved |
Genetic Panel for Inherited Cardiac Conditions | Genetic | Cardiomyopathy Risk | Family | Inherited Heart Disorders | Invitae | FDA Approved |
Testing for Kearns-Sayre Syndrome | Genetic | Mitochondrial Disorders | General | Kearns-Sayre Syndrome | Various Labs | FDA Approved |
Autosomal Dominant Polycystic Kidney Disease Testing | Genetic | Renal Disorders | General | ADPKD | GeneDx | FDA Approved |
Genetic Testing for Mastocytosis | Genetic | Allergic Disorders | General | Mast Cell Disorders | Various Labs | FDA Approved |
Testing for PKU | Genetic | Metabolic Disorders | Newborn | Phenylketonuria | Various Labs | FDA Approved |
Genetic Test for Birt-Hogg-Dubé Syndrome | Genetic | Cancer Risk | General | Birt-Hogg-Dubé Syndrome | GeneDx | FDA Approved |
Comprehensive DNA Repair Gene Test | Genetic | Cancer Risk Assessment | Family | DNA Repair Disorders | Ambry Genetics | FDA Approved |
Genetic Testing for Scurvy | Genetic | Vitamin Deficiency | General | Vitamin C Deficiency | Various Labs | FDA Approved |
Testing for Weissenbacher-Zweymüller Syndrome | Genetic | Rare Disorders | General | Weissenbacher-Zweymüller Syndrome | Various Labs | FDA Approved |
APOE Genotyping for Alzheimer's Risk | Genetic | Risk Assessment | General | Alzheimer's Disease | Various Labs | FDA Approved |
Testing for Muir-Torre Syndrome | Genetic | Cancer Risk | Family | Muir-Torre Syndrome | Invitae | FDA Approved |
Testing for Neurofibromatosis Type 2 | Genetic | Tumor Syndromes | General | Neurofibromatosis Type 2 | GeneDx | FDA Approved |
Genetic Testing for Hyperimmunoglobulin E Syndrome | Genetic | Immunodeficiency Disorders | General | Hyper-IgE Syndrome | Ambry Genetics | FDA Approved |
Retinoblastoma Genetic Testing | Genetic | Eye Cancer Risk | Family | Retinoblastoma | Invitae | FDA Approved |
Genetic Panel for Myelodysplastic Syndromes | Genetic | Blood Disorders | General | Myelodysplastic Syndromes | Ambry Genetics | FDA Approved |
Genetic Testing for Severe Combined Immunodeficiency | Genetic | Immunodeficiency Disorders | Newborn | SCID | Various Labs | FDA Approved |
Test for Aicardi Syndrome | Genetic | Neurodevelopmental Disorders | General | Aicardi Syndrome | GeneDx | FDA Approved |
Comprehensive Metabolism Panel | Genetic | Metabolic Disorders | General | Various Metabolic Conditions | Invocation | Research Use |
Testing for THAP11-related Disorders | Genetic | Intellectual Disabilities | General | THAP11 Disorders | GeneDx | FDA Approved |
Genetic Testing for Churg-Strauss Syndrome | Genetic | Systemic Vasculitis | General | Churg-Strauss Syndrome | GeneDx | FDA Approved |
SAR1B Genetic Testing | Genetic | Lipid Disorders | General | SAR1B Deficiency | GeneDx | FDA Approved |
Testing for COACH Syndrome | Genetic | Mitochondrial Disorders | General | COACH Syndrome | Various Labs | FDA Approved |
Hereditary Breast and Ovarian Cancer Testing | Genetic | Cancer Risk | Family | BRCA1/2 Syndromes | Myriad Genetics | FDA Approved |
Genetic Testing for Ornithine Transcarbamylase Deficiency | Genetic | Urea Cycle Disorders | General | OTC Deficiency | Various Labs | FDA Approved |
Iron Overload Genetic Testing | Genetic | Iron Metabolism Disorders | General | Hereditary Hemochromatosis | GeneDx | FDA Approved |
Test for PODXL-related Disorders | Genetic | Kidney Disorders | General | PODXL Disorders | GeneDx | FDA Approved |
Genetic Test for HUS | Genetic | Hemolytic Uremic Syndrome | General | HUS Risk | Various Labs | FDA Approved |
Testing for VACTERL Association | Genetic | Congenital Disorders | General | VACTERL Association | GeneDx | FDA Approved |
Genetic Panel for Pancreatic Cancer Risk | Genetic | Pancreatic Cancer Assessment | Family | Pancreatic Cancer | Invitae | FDA Approved |
Genetic Testing for Phelan-McDermid Syndrome | Genetic | Developmental Disorders | General | Phelan-McDermid Syndrome | GeneDx | FDA Approved |
Comprehensive Gastrointestinal Genetic Testing | Genetic | GI Disorders | General | Various GI Conditions | Ambry Genetics | FDA Approved |
Genetic Testing for RASopathies | Genetic | Genetic Syndromes | General | RASopathies | GeneDx | FDA Approved |
Genetic Testing for Prader-Willi Syndrome | Genetic | Endocrine Disorders | General | Prader-Willi Syndrome | GeneDx | FDA Approved |
Genetic Testing for Ehlers-Danlos Syndrome | Genetic | Connective Tissue Disorders | General | Ehlers-Danlos Syndrome | Various Labs | FDA Approved |
Genomic Medicine in Diabetes Testing | Genetic | Diabetes Risk | General | Diabetes Mellitus | Various Labs | FDA Approved |
Genetic Testing for Aaron's Syndrome | Genetic | Developmental Disorders | General | Aaron's Syndrome | GeneDx | FDA Approved |
Testing for Coffin-Lowry Syndrome | Genetic | X-linked Mental Retardation | General | Coffin-Lowry Syndrome | Various Labs | FDA Approved |
Genetic Testing for Klinefelter Syndrome | Genetic | Chromosomal Disorders | General | Klinefelter Syndrome | GeneDx | FDA Approved |
Testing for Cleft Lip/Palate Syndromes | Genetic | Congenital Defects | General | Cleft Lip/Palate | Various Labs | FDA Approved |
Genetic Testing for Noonan Syndrome | Genetic | Growth Disorders | General | Noonan Syndrome | GeneDx | FDA Approved |
Testing for Turner Syndrome | Genetic | Chromosomal Disorders | General | Turner Syndrome | Various Labs | FDA Approved |
Genetic Risk Assessment for Diabetes | Genetic | Diabetes Traits | General | Type 1 and Type 2 Diabetes | Various Labs | FDA Approved |
Testing for Williams Syndrome | Genetic | Developmental Disorders | General | Williams Syndrome | Various Labs | FDA Approved |
Genetic Testing for X-linked Agammaglobulinemia | Genetic | Immunodeficiency Disorders | General | XLA | GeneDx | FDA Approved |
Fragile X Expanded Allele Testing | Genetic | Autism and Developmental Delays | General | Fragile X Syndrome | Various Labs | FDA Approved |
Testing for Usher Syndrome Type 1 | Genetic | Hearing and Vision Disorders | General | Usher Syndrome | GeneDx | FDA Approved |
Genetic Testing for Polycystic Ovary Syndrome | Genetic | Endocrine Disorders | General | PCOS Genetic Test | Various Labs | FDA Approved |
Testing for Cowden Syndrome | Genetic | Tumor Syndromes | General | Cowden Syndrome | GeneDx | FDA Approved |
Genetic Testing for Familial Meningioma | Genetic | Brain Tumor Risk | Family | Meningioma | Invitae | FDA Approved |
Testing for Myhre Syndrome | Genetic | Skeletal Disorders | General | Myhre Syndrome | GeneDx | FDA Approved |
Genetic Testing for Hibernating Big Arm Syndrome | Genetic | Rare Disorders | General | Hibernating Big Arm Syndrome | GeneDx | FDA Approved |
Testing for Langerhans Cell Histiocytosis | Genetic | Hematologic Disorders | General | LCH | Various Labs | FDA Approved |
Genetic Testing for Warfarin Sensitivity | Pharmacogenomic | Drug Metabolism | General | Warfarin Sensitivity | Various Labs | FDA Approved |
Testing for Bardet-Biedl Syndrome | Genetic | Genetic Syndromes | General | Bardet-Biedl Syndrome | GeneDx | FDA Approved |
Genetic Profile for Fertility | Genetic | Fertility Assessment | General | Fertility Issues | Various Labs | FDA Approved |
Comprehensive Skin Cancer Genetic Testing | Genetic | Skin Cancer Risk | General | Skin Cancer Risk Assessment | Invitae | FDA Approved |
Testing for Marfan Syndrome | Genetic | Connective Tissue Disorders | General | Marfan Syndrome | GeneDx | FDA Approved |
Genetic Testing for Hypohidrotic Ectodermal Dysplasia | Genetic | Skin Disorders | General | Ectodermal Dysplasia | Various Labs | FDA Approved |
Testing for VHL Syndrome | Genetic | Tumor Syndromes | General | von Hippel-Lindau | GeneDx | FDA Approved |
Genetic Testing for Noonan syndrome 3 | Genetic | Growth and Development | General | Noonan Syndrome | Various Labs | FDA Approved |
Testing for Smith-Lemli-Opitz Syndrome | Genetic | Metabolic Disorders | General | SLO Syndrome | Various Labs | FDA Approved |
Genetic Testing for ABCD Syndrome | Genetic | Developmental Delays | General | ABCD Syndrome | GeneDx | FDA Approved |
MGMT Methylation Testing | Diagnostic | Brain Tumor Assessment | Oncology | Gliomas | Various Labs | FDA Approved |
Genetic Test for KIF1A-related Disorders | Genetic | Neurodevelopmental Disorders | General | KIF1A Disorders | GeneDx | FDA Approved |
Testing for Crigler-Najjar Syndrome | Genetic | Liver Disorders | General | Crigler-Najjar Syndrome | Various Labs | FDA Approved |
Genetic Testing for Wolfram Syndrome | Genetic | Diabetes Insipidus | General | Wolfram Syndrome | GeneDx | FDA Approved |
Testing for Thrombocytopenia-absent radius syndrome | Genetic | Blood Disorders | General | TAR Syndrome | Various Labs | FDA Approved |
Genetic Test for Cacna1c-related Disorders | Genetic | Cardiovascular Disorders | General | Cacna1c Variants | GeneDx | FDA Approved |
Testing for Huntington Disease | Genetic | Neurodegenerative Disorders | General | Huntington's Disease | Various Labs | FDA Approved |
Genetic Testing for Sperm Analysis | Genetic | Fertility Assessment | General | Sperm Quality Assessment | Various Labs | FDA Approved |
Testing for A-Beta-Syndrome | Genetic | Rare Disorders | General | A-Beta Syndrome | GeneDx | FDA Approved |
Genetic Testing for Pankreas Divisum | Genetic | Pancreatic Disorders | General | Pankreas Divisum | Various Labs | FDA Approved |
Testing for Gaucher Disease Type 3 | Genetic | Metabolic Disorders | General | Gaucher Type 3 | GeneDx | FDA Approved |
Genetic Testing for Tuberous Sclerosis | Genetic | Tumor Syndromes | General | Tuberous Sclerosis | Invitae | FDA Approved |
Testing for Connexin 26-related Hearing Loss | Genetic | Hearing Disorders | General | Connexin 26 | GeneDx | FDA Approved |
Genetic Testing for Dandy-Walker Malformation | Genetic | Brain Development Disorders | General | Dandy-Walker Syndrome | Various Labs | FDA Approved |
Testing for Maple Syrup Urine Disease | Genetic | Metabolic Disorders | Newborn | MSUD | Various Labs | FDA Approved |
Genetic Testing for Turner Syndrome Mix | Genetic | Chromosomal Disorders | General | Turner Syndrome Variants | GeneDx | FDA Approved |
Testing for Genomics in Cancer Treatment | Genetic | Cancer Treatment | Oncology | Targeted Therapy | Various Labs | FDA Approved |
Genetic Testing for Lynch Syndrome Variants | Genetic | Colorectal Cancer Risk | Family | Lynch Variants | Myriad Genetics | FDA Approved |
Testing for Congenital Hypothyroidism | Genetic | Endocrine Disorders | Newborn | Congenital Hypothyroidism | Various Labs | FDA Approved |
Testing for Eosinophilic Esophagitis | Genetic | GI Disorders | General | Eosinophilic Esophagitis | GeneDx | FDA Approved |
Genetic Testing for Pediatric Neurology | Genetic | Neurological Disorders | Pediatrics | Pediatric Neurological Disorders | Various Labs | FDA Approved |
Testing for XLID | Genetic | Mental Retardation | General | X-Linked ID | GeneDx | FDA Approved |
Genetic Test for 22q11.2 Deletion Syndrome | Genetic | Chromosomal Disorders | General | 22q11.2 Deletion | GeneDx | FDA Approved |
Genetic Testing for CADASIL | Genetic | Vascular Disorders | General | CADASIL | Various Labs | FDA Approved |
Testing for Frasier Syndrome | Genetic | Kidney Disorders | General | Frasier Syndrome | GeneDx | FDA Approved |
Genetic Testing for Waterhouse-Friderichsen Syndrome | Genetic | Adrenal Disorders | General | Waterhouse-Friderichsen | Various Labs | FDA Approved |
Testing for Becton-Dickinson Syndrome | Genetic | Metabolic Disorders | General | Becton-Dickinson Syndrome | GeneDx | FDA Approved |
Genetic Testing for Dystonia | Genetic | Movement Disorders | General | Dystonia | GeneDx | FDA Approved |
Testing for Medullary Thyroid Carcinoma | Genetic | Endocrine Disorders | General | Medullary Thyroid Cancer | GeneDx | FDA Approved |
Genetic Testing for HNRNPH2-related Disorders | Genetic | Neurodevelopmental Disorders | General | HNRNPH2 Variants | GeneDx | FDA Approved |
Testing for LADD Syndrome | Genetic | Skeletal Disorders | General | LADD Syndrome | GeneDx | FDA Approved |
Testing for Pallister-Killian Mosaic Syndrome | Genetic | Chromosomal Disorders | General | Pallister-Killian Syndrome | GeneDx | FDA Approved |
Testing for Marfan-related Disorders | Genetic | Connective Tissue Disorders | General | Marfan Spectrum Disorders | GeneDx | FDA Approved |
Testing for Williams-Beuren Syndrome | Genetic | Developmental Disorders | General | Williams-Beuren Syndrome | Genetic Health | FDA Approved |
Genetic Testing for Oligodontia | Genetic | Dental Disorders | General | Oligodontia Risk Factors | GeneDx | FDA Approved |
Genetic Testing for Osteopetrosis | Genetic | Bone Density Disorders | General | Osteopetrosis | Various Labs | FDA Approved |
Testing for Sotos Syndrome | Genetic | Growth Disorders | General | Sotos Syndrome | GeneDx | FDA Approved |
Genetic Testing for Neurodegenerative Conditions | Genetic | Neurodegeneration | General | Variety of Conditions | Various Labs | FDA Approved |
Testing for VATER Association | Genetic | Congenital Malformations | General | VATER Association | GeneDx | FDA Approved |
Genetic Risk Testing for Drug Addiction | Pharmacogenomic | Substance Use Disorders | General | Addiction Profile | Various Labs | FDA Approved |
Comprehensive Autism Genetic Testing | Genetic | Psychiatric Disorders | General | Autism Spectrum Disorders | GeneDx | FDA Approved |
Testing for Argininosuccinate Lyase Deficiency | Genetic | Metabolic Disorders | General | Argininosuccinate Lyase Deficiency | Various Labs | FDA Approved |
Testing for Epilepsy | Genetic | Neurological Disorders | General | Epilepsy Types | GeneDx | FDA Approved |
Genetic Testing for Sarcoidosis | Genetic | Inflammatory Disorders | General | Sarcoidosis Risks | Various Labs | FDA Approved |
Testing for Barrett's Esophagus | Genetic | Esophageal Disorders | General | Barrett's Esophagus | GeneDx | FDA Approved |
Genetic Testing for CNS Disorders | Genetic | Central Nervous System Disorders | General | CNS Disorders | Various Labs | FDA Approved |
Testing for Mitochondrial Encephalomyopathy | Genetic | Neuromuscular Disorders | General | Mitochondrial Disorders | GeneDx | FDA Approved |
Genetic Testing for Hypomagnesemia | Genetic | Electrolyte Disorders | General | Hypomagnesemia Risks | GeneDx | FDA Approved |
Testing for Basal Cell Nevus Syndrome | Genetic | Skin Disorders | General | Basal Cell Nevus | GeneDx | FDA Approved |
Genetic Testing for Hyperparathyroidism | Genetic | Endocrine Disorders | General | Hyperparathyroidism | Various Labs | FDA Approved |
Testing for Congenital Adrenal Hyperplasia | Genetic | Endocrine Disorders | General | Congenital Adrenal Hyperplasia | Various Labs | FDA Approved |
Genetic Testing for Polygenic Risk Score | Genetic | Disease Risk Assessment | General | Polygenic Traits | Various Labs | FDA Approved |
Testing for Multisystem Inflammatory Syndrome | Genetic | Inflammatory Disorders | General | MIS-C Risk | GeneDx | FDA Approved |
Genetic Testing for Albright Hereditary Osteodystrophy | Genetic | Metabolic Disorders | General | Albright Syndrome | GeneDx | FDA Approved |
Testing for Blue Rubber Bleb Nevus Syndrome | Genetic | Vascular Disorders | General | BRBNS | GeneDx | FDA Approved |
Genetic Testing for Idiopathic Pulmonary Fibrosis | Genetic | Lung Disorders | General | IPF Risks | GeneDx | FDA Approved |
Testing for FAP | Genetic | Colon Cancer Risk | General | Familial Adenomatous Polyposis | Myriad Genetics | FDA Approved |
Testing for Borna Disease | Genetic | Viral Disorders | General | Borna Disease | Various Labs | FDA Approved |
Genetic Testing for Fanconi Anemia | Genetic | Bone Marrow Disorders | General | Fanconi Anemia | GeneDx | FDA Approved |
Testing for Gitelman Syndrome | Genetic | Electrolyte Disorders | General | Gitelman Syndrome | Various Labs | FDA Approved |
Genetic Testing for Sturge-Weber Syndrome | Genetic | Neurocutaneous Disorders | General | Sturge-Weber | GeneDx | FDA Approved |
Testing for Bietti Crystalline Dystrophy | Genetic | Eye Disorders | General | Bietti Dystrophy | GeneDx | FDA Approved |
Genetic Testing for Thalassemia Trait | Carrier | Blood Disorders | General | Thalassemia Trait | Various Labs | FDA Approved |
Genetic Testing for Maple Syrup Urine Disease Carrier | Carrier | Metabolic Disorders | General | MSUD Carrier Status | Various Labs | FDA Approved |
Testing for Multiple Endocrine Neoplasia | Genetic | Endocrine Disorders | General | MEN Syndromes | GeneDx | FDA Approved |
Genetic Testing for Glutaric Acidemia Type 1 | Genetic | Metabolic Disorders | General | Glutaric Acidemia | Various Labs | FDA Approved |
Testing for IDH1/IDH2 Mutations | Genetic | Tumor Genetics | General | IDH-mutant Tumors | Various Labs | FDA Approved |
Genetic Testing for G6PD Deficiency | Genetic | Blood Disorders | General | G6PD Deficiency | Various Labs | FDA Approved |
Testing for KAT6A-related Disorders | Genetic | Neurodevelopmental Disorders | General | KAT6A Variants | GeneDx | FDA Approved |
Genetic Risk Testing for Obesity | Genetic | Metabolic Disorders | General | Weight Management | Various Labs | FDA Approved |
Testing for Impaired Glucose Tolerance | Genetic | Diabetes Risks | General | Metabolic Assessment | GeneDx | FDA Approved |
Genetics in Pregnancy Testing | Genetic | Prenatal Assessment | Pregnant | Family Planning | Various Labs | FDA Approved |
Comprehensive Genetic Test for Skin Cancer | Genetic | Cancer Risk Assessment | General | Skin Cancer Markers | Various Labs | FDA Approved |
Genetic Testing for Betel Nut-related Disorders | Genetic | Oral Disorders | General | Tobacco and Betel Nut Use | Various Labs | FDA Approved |
Testing for Congenital Thrombocytopenia | Genetic | Blood Disorders | General | Congenital Thrombocytopenia | GeneDx | FDA Approved |
Genetic Testing for Dystrophic Epidermolysis Bullosa | Genetic | Skin Disorders | General | Dystrophic EB | GeneDx | FDA Approved |
Testing for Klinefelter Syndrome Carrier Status | Carrier | Chromosomal Disorders | General | Klinefelter Traits | Various Labs | FDA Approved |
Testing for Achondrogenesis | Genetic | Skeletal Dysplasia | General | Achondrogenesis | GeneDx | FDA Approved |
Genetic Testing for Temporal Lobe Epilepsy | Genetic | Neuromuscular Disorders | General | Temporal Epilepsy Risk | GeneDx | FDA Approved |
Comprehensive Cardiomyopathy Genetic Panel | Genetic | Cardiac Disorders | General | Cardiomyopathy | Various Labs | FDA Approved |
Testing for Ehlers-Danlos Syndrome Hypermobile Type | Genetic | Connective Tissue Disorders | General | Hypermobile EDS | GeneDx | FDA Approved |
Testing for PAX6-related Disorders | Genetic | Eye Disorders | General | PAX6 Variants | GeneDx | FDA Approved |
Testing for CXL Syndrome | Genetic | Metabolic Disorders | General | CXL Syndrome | GeneDx | FDA Approved |
Genetic Testing for Pheochromocytoma | Genetic | Tumor Risk Assessment | Family | Pheochromocytoma | Invitae | FDA Approved |
Testing for Cohen Syndrome | Genetic | Neurodevelopmental Disorders | General | Cohen Syndrome | GeneDx | FDA Approved |
Comprehensive Genetic Testing for Thyroid Disorders | Genetic | Endocrine Disorders | General | Thyroid Conditions | Various Labs | FDA Approved |
Testing for Pathogenic FAP Variants | Genetic | Cancer Risk | Family | Familial Adenomatous Polyposis | GeneDx | FDA Approved |
Testing for Nonsense-Mediated Decay Disorders | Genetic | Genetic Disorders | General | Nonsense-Mediated Decay | GeneDx | FDA Approved |
Genetic Testing for Galactosemia | Genetic | Metabolic Disorders | General | Galactosemia Carrier Status | GeneDx | FDA Approved |
Testing for Mucopolysaccharidosis IX | Genetic | Metabolic Disorders | General | MPS IX | GeneDx | FDA Approved |
Genetic Testing for cystic fibrosis carriers | Carrier | Lung Disease | General | Cystic Fibrosis | Various Labs | FDA Approved |
Testing for Hereditary Nonpolyposis Colorectal Cancer | Genetic | Cancer Risk Assessment | Family | Lynch Syndrome | Myriad Genetics | FDA Approved |
Genetic Testing for Type 1 Diabetes Risk | Genetic | Diabetes Risk | General | Type 1 Diabetes Risk Factors | GeneDx | FDA Approved |
Testing for Digan Syndrome | Genetic | Developmental Disorders | General | Digan Syndrome | GeneDx | FDA Approved |
Genetic Testing for Lichtenstein's Disease | Genetic | Skin Disorders | General | Lichtenstein's Disease | GeneDx | FDA Approved |
Genetic Testing for Hypertrophic Cardiomyopathy | Genetic | Cardiac Disorders | Family | HCM Risk Assessment | GeneDx | FDA Approved |
Testing for Renal Tubular Acidosis | Genetic | Kidney Disorders | General | RTA Type | Various Labs | FDA Approved |
Genetic Testing for Retinitis Pigmentosa | Genetic | Eye Disorders | General | Retinitis Pigmentosa | GeneDx | FDA Approved |
Testing for Ocular Albinism | Genetic | Eye Disorders | General | Ocular Albinism | GeneDx | FDA Approved |
Genetic Testing for Prostate Cancer Risk | Genetic | Cancer Risk Assessment | Family | Prostate Cancer | Myriad Genetics | FDA Approved |
Testing for Becker Muscular Dystrophy | Genetic | Muscular Disorders | General | Becker's Dystrophy | GeneDx | FDA Approved |
Testing for Myotonic Dystrophy Type 2 | Genetic | Muscular Disorders | General | Myotonic Dystrophy | GeneDx | FDA Approved |
Genetic Testing for KCNQ2-related disorders | Genetic | Neurological Disorders | General | KCNQ2 Variants | GeneDx | FDA Approved |
Testing for Spinocerebellar Ataxia | Genetic | Movement Disorders | General | Spinocerebellar Ataxia | GeneDx | FDA Approved |
Genetic Testing for Non-Syndromic Hearing Loss | Genetic | Hearing Disorders | General | Hearing Loss Genes | GeneDx | FDA Approved |
Testing for Semi-Dominant Ehlers-Danlos Syndrome | Genetic | Connective Tissue Disorders | General | Semi-Dominant EDS | GeneDx | FDA Approved |
Genetic Testing for Marfan Syndrome | Genetic | Connective Tissue Disorders | General | Marfan Traits | Myriad Genetics | FDA Approved |
Testing for Malignant Hyperthermia | Genetic | Anesthetic Complications | General | Malignant Hyperthermia Risk | Various Labs | FDA Approved |
Testing for Schimke Immuno-osseous Dysplasia | Genetic | Immune Disorders | General | Schimke Syndrome | GeneDx | FDA Approved |
Genetic Testing for Rheumatoid Factor | Genetic | Autoimmune Disorders | General | Rheumatoid Arthritis | Various Labs | FDA Approved |
Testing for Neurodegenerative Diseases Testing | Genetic | Neurodegenerative Disorders | General | Dementia Risk Assessments | GeneDx | FDA Approved |
Testing for PCH | Genetic | Cerebellar Ataxia | General | PCH Risk Factors | GeneDx | FDA Approved |
Genetic Testing for Pituitary Disorders | Genetic | Endocrine Disorders | General | Pituitary Conditions | Various Labs | FDA Approved |
Testing for Kearns-Sayre Syndrome | Genetic | Mitochondrial Disorders | General | Kearns-Sayre Syndrome | GeneDx | FDA Approved |
Genetic Testing for Ca2+ Channelopathies | Genetic | Neuromuscular Disorders | General | Ca2+ Channel Disorders | GeneDx | FDA Approved |
Genetic Testing for Fetal Alcohol Spectrum Disorders | Genetic | Developmental Delays | General | FASD Risk Assessment | Various Labs | FDA Approved |
Genetic Testing for Chiari Malformation | Genetic | Neurological Disorders | General | Chiari Malformation | GeneDx | FDA Approved |
Testing for Holoprosencephaly | Genetic | Brain Development Disorders | General | Holoprosencephaly Risk | GeneDx | FDA Approved |
Testing for Phosphomannomutase 2 Deficiency | Genetic | Metabolic Disorders | General | PMM2 Deficiency | GeneDx | FDA Approved |
Genetic Testing for Tetrahydrobiopterin Deficiency | Genetic | Metabolic Disorders | General | PKU Variants | GeneDx | FDA Approved |
Testing for SLC16A12-related disorders | Genetic | Kidney Disorders | General | SLC16A12 Deficiency | GeneDx | FDA Approved |
Genetic Testing for TMED10 | Genetic | Neuromuscular Disorders | General | TMED10 Variants | GeneDx | FDA Approved |
Testing for Urethral Atresia | Genetic | Congenital Defects | General | Urethral Atresia Risk Factors | GeneDx | FDA Approved |
Genetic Testing for X-Linked SCID | Genetic | Immunodeficiency Disorders | General | X-Linked Severe Combined Immunodeficiency | Various Labs | FDA Approved |
Genetic Testing for AAAS-associated Disorders | Genetic | Endocrine Disorders | General | AAAS Disorders | GeneDx | FDA Approved |
Testing for Pulmonary Alveolar Proteinosis | Genetic | Lung Disorders | General | Pulmonary Alveolar Proteinosis | GeneDx | FDA Approved |
Genetic Testing for Dipeptidyl Peptidase-4 Deficiency | Genetic | Glyco-Disorders | General | DPP-IV Deficiency | GeneDx | FDA Approved |
Testing for ALL | Genetic | Blood Disorders | General | Acute Lymphoblastic Leukemia | GeneDx | FDA Approved |
Genetic Testing for Cystic Fibrosis Modifier Genes | Genetic | Lung Disorders | General | CF Modifiers | GeneDx | FDA Approved |
Testing for Rabson-Mendenhall Syndrome | Genetic | Endocrine Disorders | General | Rabson-Mendenhall Syndrome | GeneDx | FDA Approved |
Genetic Testing for Severe Scissor-Gait Dystonia | Genetic | Neuromuscular Disorders | General | Scissor-Gait | GeneDx | FDA Approved |
Testing for Efficacy of Anti-Psychotic Drugs | Pharmacogenomic | Psychiatric Disorders | General | Anti-Psychotic Response | Various Labs | FDA Approved |
Genetic Testing for Y-chromosome microdeletions | Genetic | Infertility | General | Male Infertility | GeneDx | FDA Approved |
Testing for Cystinosis Carrier Status | Carrier | Metabolic Disorders | General | Cystinosis | Various Labs | FDA Approved |
Testing for Alport Syndrome Carrier Status | Carrier | Kidney Disorders | General | Alport Carrier Risk | Various Labs | FDA Approved |
Testing for Hearing Loss due to Connexin 30 | Genetic | Hearing Disorders | General | Connexin 30 | GeneDx | FDA Approved |
Genetic Testing for SAA-related Disorders | Genetic | Immuno-inflammatory Disorders | General | SAA Disorders | GeneDx | FDA Approved |
Testing for Agammaglobulinemia | Genetic | Immunodeficiency Disorders | General | XLA Risk | GeneDx | FDA Approved |
Testing for MCL1 Associated Disorders | Genetic | Cancer Risk | General | MCL1 Associated Variants | GeneDx | FDA Approved |
Testing for AKU | Genetic | Metabolic Disorders | General | Alcaptonuria | GeneDx | FDA Approved |
Testing for Brachyplasia | Genetic | Skeletal Disorders | General | Brachyplasia | GeneDx | FDA Approved |
Testing for WAGR Syndrome | Genetic | Chromosomal Disorders | General | WAGR Syndrome | GeneDx | FDA Approved |
Genetic Testing for Spondyloepiphyseal Dysplasia | Genetic | Skeletal Disorders | General | SED Risk | GeneDx | FDA Approved |
Examining Mycobacterium leprae strains | Genetic | Infectious Diseases | General | Leprosy Genetics | Various Labs | FDA Approved |
Testing for Wiskott-Aldrich Syndrome | Genetic | Immunodeficiency Disorders | General | WAS Disorders | GeneDx | FDA Approved |
Testing for GJB2-Related Hearing Loss | Genetic | Hearing Disorders | General | GJB2 Variants | GeneDx | FDA Approved |
Genetic Testing for MCD | Genetic | Chromosomal Disorders | General | MCD Risk Factors | GeneDx | FDA Approved |
Testing for RET Pathway Disorders | Genetic | Tumor Syndromes | General | RET Pathway Tumors | GeneDx | FDA Approved |
Testing for Secondary Male Infertility | Genetic | Infertility | General | Infertility Factors | GeneDx | FDA Approved |
Genetic Testing for Thymoma Genotyping | Genetic | Tumor Markers | General | Thymoma Genetic Assessment | GeneDx | FDA Approved |
Testing for LCH | Genetic | Hematologic Disorders | General | LCH Genetic Profile | GeneDx | FDA Approved |
Testing for Turner Syndrome Associated Variants | Genetic | Chromosomal Disorders | General | Turner Traits | GeneDx | FDA Approved |
Testing for Erythropoietic Protoporphyria | Genetic | Skin Disorders | General | EPP Risk Factors | GeneDx | FDA Approved |
Genetic Testing for Rare Tumor Panel | Genetic | Tumor Risk | General | Rare Tumors Risk Assessment | GeneDx | FDA Approved |
Testing for ATAXIA | Genetic | Neuropathy Disorders | General | Ataxia Risk Factors | GeneDx | FDA Approved |
Genetic Testing for MUD | Genetic | Hematologic Disorders | General | MUD Genetic Profile | GeneDx | FDA Approved |
Testing for Infantile-onset Pompe Disease | Genetic | Muscle Disorders | General | Pompe Disease Risk | GeneDx | FDA Approved |
Genetic Testing for NOS3 | Genetic | Cardiac Disorders | General | NOS3 Variants | GeneDx | FDA Approved |
Testing for Familial Hypercholesterolemia | Genetic | Lipid Disorders | General | Lipid Metabolism Issues | GeneDx | FDA Approved |
Genetic Test for Sarcopenia-related Disorders | Genetic | Muscle Weakness Disorders | General | Sarcopenia Risk Assessment | GeneDx | FDA Approved |
Testing for TTS Syndrome | Genetic | Skeletal Disorders | General | TTS Risks | GeneDx | FDA Approved |
Testing for EDD | Genetic | Genetic Predisposition Disorders | General | EDD Risk Factors | GeneDx | FDA Approved |
Genetic Testing for TSEN54 Mutation-induced Disorders | Genetic | Neurodegenerative Disorders | General | TSEN54 Risks | GeneDx | FDA Approved |
Testing for X-linked Myotubular Myopathy | Genetic | Muscle Disorders | General | Myotubular Myopathy | GeneDx | FDA Approved |
Testing for WI38-related Disorders | Genetic | Aging Disorders | General | WI38 Risks | GeneDx | FDA Approved |
Genetic Testing for Anemia Risk Factors | Genetic | Blood Disorders | General | Anemia Variants | GeneDx | FDA Approved |
Testing for ENPP1 Deficiency | Genetic | Metabolic Disorders | General | ENPP1 Disorders | GeneDx | FDA Approved |
Genetic Testing for EPI | Genetic | Pancreatic Disorders | General | Exocrine Pancreatic Insufficiency | GeneDx | FDA Approved |
Testing for 15q Duplication Syndrome | Genetic | Chromosomal Disorders | General | 15q Duplication | GeneDx | FDA Approved |
Genetic Risk Testing for Polygenic Obesity | Genetic | Obesity Risk | General | Polygenic Obesity | GeneDx | FDA Approved |